Physician profile
James Michael Calhoun
NPI 1376531814
$27,070.83
in general payments reported to CMS, 2019-2025
22 companies · $9,492 in 2025
The $9,492 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $2,702 · 2021: $2,809 · 2022: $1,355 · 2023: $6,861 · 2024: $3,317 · 2025: $9,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $5,334 · Food and Beverage: $1,462 · Education: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,642.00 |
| Travel and Lodging | $5,333.91 |
| Food and Beverage | $1,461.94 |
| Education | $232.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Life Spine, INC. | $15,928.74 | 2023-2025 | Prolink Barb, Pro-Link Stand-Alone Cervical Spacer System, Pro-Link Ti |
| Southern Spine, LLC | $4,750.00 | 2020-2021 | |
| Arthrex, INC. | $2,041.54 | 2024 | |
| Nevro Corp. | $1,380.51 | 2022-2024 | Senza |
| Midsouth Orthopedics INC. | $1,023.31 | 2024 | |
| Providence Medical Technology, INC. | $487.67 | 2019-2025 | |
| Integrity Implants INC. | $482.30 | 2019-2021 | |
| Merz North America, INC. | $244.51 | 2019 | |
| Surgalign Spine Technologies, INC. | $144.63 | 2020 | |
| Relievant Medsystems, INC. | $122.12 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $105.20 | 2022-2025 | Belbuca |
| Gs Solutions, INC. | $88.30 | 2021 | |
| Si-Bone, INC. | $52.25 | 2024 | |
| Medtronic, INC. | $42.60 | 2022-2024 | Intellis Adaptivestim |
| Radius Health, INC. | $37.45 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $30.02 | 2022 | |
| Cerapedics INC. | $29.83 | 2022 | |
| Boston Scientific Corporation | $27.06 | 2023 | Wavewriter Alpha Prime 16 |
| Baudax Bio INC. | $21.25 | 2022 | |
| Allergan, INC. | $11.98 | 2020 | |
| Amarin Pharma, INC. | $11.76 | 2019 | |
| Vgi Medical, LLC | $7.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Calhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.